IBDEI0KJ ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9059,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ diffuse crescentic glomrlneph
 ;;^UTILITY(U,$J,358.3,9059,1,4,0)
 ;;=4^N05.7
 ;;^UTILITY(U,$J,358.3,9059,2)
 ;;=^5015548
 ;;^UTILITY(U,$J,358.3,9060,0)
 ;;=N05.8^^69^617^50
 ;;^UTILITY(U,$J,358.3,9060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9060,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ oth morphologic changes
 ;;^UTILITY(U,$J,358.3,9060,1,4,0)
 ;;=4^N05.8
 ;;^UTILITY(U,$J,358.3,9060,2)
 ;;=^5134085
 ;;^UTILITY(U,$J,358.3,9061,0)
 ;;=N05.9^^69^617^51
 ;;^UTILITY(U,$J,358.3,9061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9061,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ unspec morphologic changes
 ;;^UTILITY(U,$J,358.3,9061,1,4,0)
 ;;=4^N05.9
 ;;^UTILITY(U,$J,358.3,9061,2)
 ;;=^5134086
 ;;^UTILITY(U,$J,358.3,9062,0)
 ;;=N06.0^^69^617^39
 ;;^UTILITY(U,$J,358.3,9062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9062,1,3,0)
 ;;=3^Isolated proteinuria w/ minor glomerular abnormality
 ;;^UTILITY(U,$J,358.3,9062,1,4,0)
 ;;=4^N06.0
 ;;^UTILITY(U,$J,358.3,9062,2)
 ;;=^5015549
 ;;^UTILITY(U,$J,358.3,9063,0)
 ;;=N06.1^^69^617^38
 ;;^UTILITY(U,$J,358.3,9063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9063,1,3,0)
 ;;=3^Isolated proteinuria w/ focal & segmental glomerular lesions
 ;;^UTILITY(U,$J,358.3,9063,1,4,0)
 ;;=4^N06.1
 ;;^UTILITY(U,$J,358.3,9063,2)
 ;;=^5015550
 ;;^UTILITY(U,$J,358.3,9064,0)
 ;;=N06.2^^69^617^35
 ;;^UTILITY(U,$J,358.3,9064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9064,1,3,0)
 ;;=3^Isolated proteinuria w/ diffuse membranous glomerulonephritis
 ;;^UTILITY(U,$J,358.3,9064,1,4,0)
 ;;=4^N06.2
 ;;^UTILITY(U,$J,358.3,9064,2)
 ;;=^5015551
 ;;^UTILITY(U,$J,358.3,9065,0)
 ;;=N06.3^^69^617^36
 ;;^UTILITY(U,$J,358.3,9065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9065,1,3,0)
 ;;=3^Isolated proteinuria w/ diffuse mesangial prolif glomrlneph
 ;;^UTILITY(U,$J,358.3,9065,1,4,0)
 ;;=4^N06.3
 ;;^UTILITY(U,$J,358.3,9065,2)
 ;;=^5015552
 ;;^UTILITY(U,$J,358.3,9066,0)
 ;;=N06.4^^69^617^34
 ;;^UTILITY(U,$J,358.3,9066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9066,1,3,0)
 ;;=3^Isolated proteinuria w/ diffuse endocaplry prolif glomrlneph
 ;;^UTILITY(U,$J,358.3,9066,1,4,0)
 ;;=4^N06.4
 ;;^UTILITY(U,$J,358.3,9066,2)
 ;;=^5015553
 ;;^UTILITY(U,$J,358.3,9067,0)
 ;;=N06.5^^69^617^37
 ;;^UTILITY(U,$J,358.3,9067,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9067,1,3,0)
 ;;=3^Isolated proteinuria w/ diffuse mesangiocapillary glomrlneph
 ;;^UTILITY(U,$J,358.3,9067,1,4,0)
 ;;=4^N06.5
 ;;^UTILITY(U,$J,358.3,9067,2)
 ;;=^5015554
 ;;^UTILITY(U,$J,358.3,9068,0)
 ;;=N06.6^^69^617^32
 ;;^UTILITY(U,$J,358.3,9068,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9068,1,3,0)
 ;;=3^Isolated proteinuria w/ dense deposit disease
 ;;^UTILITY(U,$J,358.3,9068,1,4,0)
 ;;=4^N06.6
 ;;^UTILITY(U,$J,358.3,9068,2)
 ;;=^5015555
 ;;^UTILITY(U,$J,358.3,9069,0)
 ;;=N06.7^^69^617^33
 ;;^UTILITY(U,$J,358.3,9069,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9069,1,3,0)
 ;;=3^Isolated proteinuria w/ diffuse crescentic glomerulonephritis
 ;;^UTILITY(U,$J,358.3,9069,1,4,0)
 ;;=4^N06.7
 ;;^UTILITY(U,$J,358.3,9069,2)
 ;;=^5015556
 ;;^UTILITY(U,$J,358.3,9070,0)
 ;;=N06.8^^69^617^40
 ;;^UTILITY(U,$J,358.3,9070,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9070,1,3,0)
 ;;=3^Isolated proteinuria w/ other morphologic lesion
 ;;^UTILITY(U,$J,358.3,9070,1,4,0)
 ;;=4^N06.8
 ;;^UTILITY(U,$J,358.3,9070,2)
 ;;=^5015557
